Dr. Tiago Reis Marques - 23 Jun 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Chief Executive Officer, Director
Signature
/s/ Dr. Tiago Reis Marques
Issuer symbol
KTTA
Transactions as of
23 Jun 2022
Net transactions value
+$4,964
Form type
4
Filing time
23 Jun 2022, 17:10:43 UTC
Previous filing
22 Dec 2021
Next filing
21 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Award $2,880 +2,900 +0.36% $0.9930 802,900 23 Jun 2022 Direct
transaction KTTA Common Stock Award $196 +200 +0.02% $0.9820 803,100 23 Jun 2022 Direct
transaction KTTA Common Stock Award $98.8 +100 +0.01% $0.9880 803,200 23 Jun 2022 Direct
transaction KTTA Common Stock Award $1,789 +1,800 +0.22% $0.9940 805,000 23 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.